Andrew Cittadine - 14 Nov 2022 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Chief Operating Officer
Signature
Kim R. Tsuchimoto, Attorney-in-fact
Issuer symbol
MNPR
Transactions as of
14 Nov 2022
Net transactions value
+$49,659
Form type
4
Filing time
16 Nov 2022, 15:58:33 UTC
Previous filing
03 Oct 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNPR Common Stock Purchase $18,159 +6,053 +74% $3.00 14,238 14 Nov 2022 Direct
transaction MNPR Common Stock Purchase $31,500 +10,000 +70% $3.15 24,238 15 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.